این سایت در حال حاضر پشتیبانی نمی شود و امکان دارد داده های نشریات بروز نباشند
صفحه اصلی
درباره پایگاه
فهرست سامانه ها
الزامات سامانه ها
فهرست سازمانی
تماس با ما
JCR 2016
جستجوی مقالات
چهارشنبه 19 آذر 1404
Iranian Journal of Basic Medical Sciences
، جلد ۲۰، شماره ۱، صفحات ۵۹-۶۶
عنوان فارسی
چکیده فارسی مقاله
کلیدواژههای فارسی مقاله
عنوان انگلیسی
2-(2-(4-Benzoylpiperazin-1-yl)ethyl)isoindoline-1,3-dione derivatives: Synthesis, docking and acetylcholinesterase inhibitory evaluation as anti-alzheimer agents
چکیده انگلیسی مقاله
Objective(s): Alzheimer’s disease (AD) as progressive cognitive decline and the most common form of dementia is due to degeneration of the cholinergic neurons in the brain. Therefore, administration of the acetylcholinesterase (AChE) inhibitors such as donepezil is the first choice for treatment of the AD. In the present study, we focused on the synthesis and anti-cholinesterase evaluation of new donepezil like analogs. Materials and Methods: A new series of phthalimide derivatives (compounds 4a-4j) were synthesized via Gabriel protocol and subsequently amidation reaction was performed using various benzoic acid derivatives. Then, the corresponding anti-acetylcholinesterase activity of the prepared derivatives (4a-4j) was assessed by utilization of the Ellman's test and obtained results were compared to donepezil. Besides, docking study was also carried out to explore the likely in silico binding interactions. Results: According to the obtained results, electron withdrawing groups (Cl, F) at position 3 and an electron donating group (methoxy) at position 4 of the phenyl ring enhanced the acetylcholinesterase inhibitory activity. Compound 4e (m-Fluoro, IC50 = 7.1 nM) and 4i (p-Methoxy, IC50 = 20.3 nM) were the most active compounds in this series and exerted superior potency than donepezil (410 nM). Moreover, a similar binding mode was observed in silico for all ligands in superimposition state with donepezil into the active site of acetylcholinesterase. Conclusion: Studied compounds could be potential leads for discovery of novel anti-Alzheimer agents in the future.
کلیدواژههای انگلیسی مقاله
نویسندگان مقاله
احمد محمدی فرانی | ahmad mohammadi farani
pharmaceutical sciences research center, faculty of pharmacy, kermanshah university of medical sciences, kermanshah, iran|department of pharmacology, toxicology and medical services, faculty of pharmacy, kermanshah university of medical sciences, kermanshah, iran
سازمان اصلی تایید شده
: دانشگاه علوم پزشکی کرمانشاه (Kermanshah university of medical sciences)
نسیبه عبدی | nasibeh abdi
students research committee, kermanshah university of medical sciences, kermanshah, iran|department of medicinal chemistry, faculty of pharmacy, kermanshah university of medical sciences, kermanshah, iran
سازمان اصلی تایید شده
: دانشگاه علوم پزشکی کرمانشاه (Kermanshah university of medical sciences)
علیرضا مرادی | alireza moradi
neurobiomedical research center, yazd shahid sadoughi university of medical sciences, yazd, iran
علیرضا علی آبادی | alireza aliabadi
pharmaceutical sciences research center, faculty of pharmacy, kermanshah university of medical sciences, kermanshah, iran|department of medicinal chemistry, faculty of pharmacy, kermanshah university of medical sciences, kermanshah, iran
سازمان اصلی تایید شده
: دانشگاه علوم پزشکی کرمانشاه (Kermanshah university of medical sciences)
نشانی اینترنتی
http://ijbms.mums.ac.ir/article_8095.html
فایل مقاله
اشکال در دسترسی به فایل - ./files/site1/rds_journals/87/article-87-314616.pdf
کد مقاله (doi)
زبان مقاله منتشر شده
en
موضوعات مقاله منتشر شده
نوع مقاله منتشر شده
Original Article
برگشت به:
صفحه اول پایگاه
|
نسخه مرتبط
|
نشریه مرتبط
|
فهرست نشریات